India's drug regulator has increased surveillance of GLP-1 weight-loss drugs amid misuse concerns Multiple generic variants have led to easier access through pharmacies, online, and clinics Inspections covered 49 entities for unauthorized sale, improper prescriptions, and misleading promotion
